Practical synthesis and SAR study of aliskiren: An orally active human renin inhibitor

被引：0
|
作者：
Dong, Hua [1 ]
Zhang, Zhi-Liu [1 ]
Huang, Lia-Hui [1 ]
Ma, Rujian [1 ]
Chen, Shu-Hui [1 ]
Li, Ge [1 ]
机构：
[1] WuXi PharmaTech Co Ltd, Shanghai 200131, Peoples R China
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
341-MEDI
引用
收藏
页码：U2696 / U2696
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates
    Coassolo, P
    Fischli, W
    Clozel, JP
    Chou, RC
    XENOBIOTICA, 1996, 26 (03) : 333 - 345
  • [22] Aliskiren, an orally effective renin inhibitor, shows dose linear pharmacokinetics in healthy volunteers.
    Vaidyanathan, S
    Limoges, D
    Yeh, C
    Dieterich, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P64 - P64
  • [23] Suppression of the renin system by the novel orally effective direct renin inhibitor aliskiren: A pooled analysis of 1612 patients with hypertension
    Gradman, Alan H.
    Flack, John M.
    Arora, Vipin
    Zhang, Jack
    Anderson, David R.
    Keefe, Deborah L.
    Satlin, Andrew
    Prescott, Margaret F.
    CIRCULATION, 2006, 114 (18) : 773 - 773
  • [24] Total Synthesis of "Aliskiren": The First Renin Inhibitor in Clinical Practice for Hypertension
    Hanessian, Stephen
    Guesne, Sebastien
    Chenard, Etienne
    ORGANIC LETTERS, 2010, 12 (08) : 1816 - 1819
  • [25] Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects
    Vaidyanathan, S
    Jermany, J
    Yeh, CM
    Bizot, MN
    Camisasca, RP
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 75A - 76A
  • [26] Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats
    Wood, JM
    Schnell, CR
    Cumin, F
    Menard, J
    Webb, RL
    JOURNAL OF HYPERTENSION, 2005, 23 (02) : 417 - 426
  • [27] Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects
    Vaidyanathan, Sujata
    Jermany, Joanne
    Yeh, ChingMing
    Bizot, Marie-Noelle
    Camisasca, Riccardo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 690 - 698
  • [28] First experience with an orally active benin inhibitor (aliskiren) in patients with chronic heart failure
    Seed, A
    Gardner, R
    McMurray, J
    Hillier, C
    Murdoch, D
    McFadyen, R
    McDonagh, T
    HEART, 2003, 89 : A57 - A57
  • [29] Antihypertensive efficacy, safety and tolerability of the orally active direct renin inhibitor aliskiren added to hydrochlorothiazide (HCTZ) in patients with grade 3 obesity and hypertension
    Prescott, Margaret
    Boye, Sam
    Le Breton, Stephanie
    Keefe, Deborah
    Jordan, Jens
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S99 - S99
  • [30] RADIOIMMUNOASSAY FOR CI-992, AN ORALLY-ACTIVE RENIN INHIBITOR
    CONNOLLY, CJC
    HODGES, JC
    KLUTCHKO, SR
    NORDBLOM, G
    BURGER, PJ
    BARKSDALE, C
    MICHNIEWICZ, B
    COOK, J
    TAYLOR, MD
    DOHERTY, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 61 - MEDI
12345